Julia Seller(@JuliaSellerm) 's Twitter Profileg
Julia Seller

@JuliaSellerm

Cardiologist in Marina Salud Hospital (Dénia) Heart failure unit. Every month 🗓 Top3 #HF trials

ID:3315051382

calendar_today09-06-2015 13:37:49

2,9K Tweets

5,2K Followers

443 Following

Follow People
CardioTeca(@cardioteca) 's Twitter Profile Photo

💊 Empagliflozina en la reducción del desarrollo de IC en pacientes con IAM y criterios de alto riesgo
👩‍⚕️Julia Seller Moya @juliasellerm

✏️👀 cardioteca.com/blog-empaglifl…

💊 Empagliflozina en la reducción del desarrollo de IC en pacientes con IAM y criterios de alto riesgo 👩‍⚕️Julia Seller Moya @juliasellerm ✏️👀 cardioteca.com/blog-empaglifl…
account_circle
Alfonso Valle(@ValleAlfonso) 's Twitter Profile Photo

The Pragmatic Urinary Sodium-based algoritHm in Acute Heart Failure

🔴 -AHF trial randomized patients to natriuresis-guided diuretic therapy or standard of care

👥309 patients
📌median baseline eGFR was 53

👉Natriuresis-guided diuretic treatment

The Pragmatic Urinary Sodium-based algoritHm in Acute Heart Failure 🔴#PUSH-AHF trial randomized patients to natriuresis-guided diuretic therapy or standard of care #HeartFailure2024 👥309 patients 📌median baseline eGFR was 53 👉Natriuresis-guided diuretic treatment
account_circle
James Januzzi Jr MD(@JJheart_doc) 's Twitter Profile Photo

A big day for treatment of obstructive . We now have a second treatment option in the class.

Amazing data. Grateful to have contributed and more data are coming!

Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy: nejm.org/doi/full/10.10…

account_circle
🕊️Fran Bermúdez-Jiménez(@FranBermudz) 's Twitter Profile Photo

😊Very happy to share with all of you our recent work published in JACC Journals

Phenotype and Clinical Outcomes in Desmin-Related Arrhythmogenic Cardiomyopathy

Has taken a lot of effort, but it's worth it. Thank you to all co-authors!

jacc.org/doi/10.1016/j.…

😊Very happy to share with all of you our recent work published in @JACCJournals #JACCEP Phenotype and Clinical Outcomes in Desmin-Related Arrhythmogenic Cardiomyopathy Has taken a lot of effort, but it's worth it. Thank you to all co-authors! jacc.org/doi/10.1016/j.…
account_circle
Alfonso Valle(@ValleAlfonso) 's Twitter Profile Photo

Semaglutide and NTproBNP in Obesity-Related HFpEF: -HFpEF Program

Semaglutide 🆚 placebo
👉↘️ NTproBNP at 20 and 52 weeks.
👉 ↗️ health status in all patients with a more pronounced impact in those with higher vs lower baseline NTproBNP.
👉 ↘️ body weight consistently

Semaglutide and NTproBNP in Obesity-Related HFpEF: #STEP-HFpEF Program Semaglutide 🆚 placebo 👉↘️ NTproBNP at 20 and 52 weeks. 👉 ↗️ health status in all patients with a more pronounced impact in those with higher vs lower baseline NTproBNP. 👉 ↘️ body weight consistently
account_circle
Alfonso Valle(@ValleAlfonso) 's Twitter Profile Photo

⚠️Postmyocardial Infarction Ventricular Aneurysm

👉rare complication
👉Adverse events include recurrent angina, reduced ventricular stroke vol-
ume with congestive heart failure, mitral regurgitation, thromboembolism, and ventricular arrhythmias
👉Multimodality imaging

⚠️Postmyocardial Infarction Ventricular Aneurysm 👉rare complication 👉Adverse events include recurrent angina, reduced ventricular stroke vol- ume with congestive heart failure, mitral regurgitation, thromboembolism, and ventricular arrhythmias 👉Multimodality imaging
account_circle
Alfonso Valle(@ValleAlfonso) 's Twitter Profile Photo

Mineralocorticoid Receptor Antagonists in and Impaired Renal Function

👥4355 ➡️6.8% experienced a ↘️ of eGFR after randomization to <30 mL/min/1.73 m2

👉risk reduction in the primary outcome with MRA therapy was similar in those who experienced a decrease in eGFR to <30

Mineralocorticoid Receptor Antagonists in #HF and Impaired Renal Function 👥4355 ➡️6.8% experienced a ↘️ of eGFR after randomization to <30 mL/min/1.73 m2 👉risk reduction in the primary outcome with MRA therapy was similar in those who experienced a decrease in eGFR to <30
account_circle
Enrique Santas(@SantasEnrique) 's Twitter Profile Photo

Marta Cobo Marcos presenting the results of the 🇪🇸 SALT-HF trial in the LBCT session European Society of Cardiology

Congrats to Marta and all the investigators 👏🏻 💪🏻❗️

Very interesting trial. Neutral results, no benefit of the addition of hypertonic saline to iv furosemide in

@MartaCoboMarcos presenting the results of the 🇪🇸 SALT-HF trial in the LBCT session #HeartFailure2024 @escardio Congrats to Marta and all the investigators 👏🏻 💪🏻❗️ Very interesting trial. Neutral results, no benefit of the addition of hypertonic saline to iv furosemide in
account_circle
Joan Carles Trullàs, MD, PhD(@jc_trullas) 's Twitter Profile Photo

EASY-HF trial. Excelent presentation from 🇧🇪 by Evelyne Meekers & Wilfried Mullens team
A nurse-led diuretic titration via POC urinary sodium sensor in AHF significantly improved natriuresis and diuresis

EASY-HF trial. Excelent presentation from 🇧🇪 by @EvelyneMeekers & @WilfriedMullens team A nurse-led diuretic titration via POC urinary sodium sensor in AHF significantly improved natriuresis and diuresis #HeartFailure2024 #sodiumistrendingtopic
account_circle
Alfonso Valle(@ValleAlfonso) 's Twitter Profile Photo

⚠️DEA-HF TRIAL

👥42

Administration of furosemide ➕ metolazone ↗️weight of sodium excreted, 🆚 furosemide alone & furosemide ➕ acetazolamide

WRF was significantly higher when adding metolazone (41%) to furosemide 🆚 furosemide alone (17%) and to

⚠️DEA-HF TRIAL #Heartfaikure2024 👥42 Administration of furosemide ➕ metolazone ↗️weight of sodium excreted, 🆚 furosemide alone & furosemide ➕ acetazolamide WRF was significantly higher when adding metolazone (41%) to furosemide 🆚 furosemide alone (17%) and to
account_circle
Alfonso Valle(@ValleAlfonso) 's Twitter Profile Photo

🔴EXCELLENT👇👇
📌Identification of three mechanistic pathways for iron-deficient HF

1️⃣meaningful systemic iron deficiency (typically TSAT <~ 15%-16% with anaemia) results in cardiomyocyte iron deficiency and dysfunction
👉↗️ in iron influx proteins and ↘️ in iron efflux

🔴EXCELLENT👇👇 📌Identification of three mechanistic pathways for iron-deficient HF 1️⃣meaningful systemic iron deficiency (typically TSAT <~ 15%-16% with anaemia) results in cardiomyocyte iron deficiency and dysfunction 👉↗️ in iron influx proteins and ↘️ in iron efflux
account_circle
CardioTeca(@cardioteca) 's Twitter Profile Photo

🆕 Guía ESC 2023 sobre el tratamiento de la endocarditis: Comentario de expertos.

📕 Rev Esp Cardiol
🔓 cardioteca.com/cardiologia-cl…

🆕 Guía ESC 2023 sobre el tratamiento de la endocarditis: Comentario de expertos. 📕 Rev Esp Cardiol 🔓 cardioteca.com/cardiologia-cl…
account_circle
Soc Esp Cardiología(@secardiologia) 's Twitter Profile Photo

.Julia Seller: 'El estudio REDUCE-AMI no demostró beneficio en el uso prolongado de betabloqueantes en pacientes con IAM + coronariografía precoz y FEVI conservada'. JóvenesSEC ow.ly/Sm9k50RB6pt

.@JuliaSellerm: 'El estudio REDUCE-AMI no demostró beneficio en el uso prolongado de betabloqueantes en pacientes con IAM + coronariografía precoz y FEVI conservada'. #BlogSEC @JovenesSec ow.ly/Sm9k50RB6pt
account_circle
Miriam Sandín(@miriamsandin) 's Twitter Profile Photo

📌Metabolitos asociados al diferente sexo podrían relacionarse con diferencias en la incidencia de accidente cerebrovascular, enfermedad coronaria, hipertensión arterial y enfermedad renal crónica.

ahajournals.org/doi/10.1161/JA…

📌Metabolitos asociados al diferente sexo podrían relacionarse con diferencias en la incidencia de accidente cerebrovascular, enfermedad coronaria, hipertensión arterial y enfermedad renal crónica. ahajournals.org/doi/10.1161/JA…
account_circle
Soc Esp Cardiología(@secardiologia) 's Twitter Profile Photo

🆕 Nueva herramienta para evaluar la capacidad de conducción en pacientes con enfermedades cardiovasculares.

⭕ ¿Si te resulta complicado el Reglamento General de Conductores? Te interesa conocer ¿Puede conducir mi paciente?

secardiologia.es/comunicacion/n…

🆕 Nueva herramienta para evaluar la capacidad de conducción en pacientes con enfermedades cardiovasculares. ⭕ ¿Si te resulta complicado el Reglamento General de Conductores? Te interesa conocer ¿Puede conducir mi paciente? secardiologia.es/comunicacion/n…
account_circle